Mode
Text Size
Log in / Sign up
N/A Completed N=121 Treatment

Remote Ischemic Conditioning (RIC) in Recipients of Brain Death Donor Livers - A Feasibility and Safety Study

Liver Failure · Carcinoma, Hepatocellular
Source: ClinicalTrials.gov NCT02635347 ↗
Enrolled (actual)
121
Serious AEs
1.1%
Results posted
Aug 2019
Primary outcomePrimary: Percentage of Participants Completing Entire Intervention Protocol — 70.96 percentage of participants

Summary

This study will assess the feasibility of lower limb-ischemia induced Remote Ischemic Conditioning (RIC) in the perioperative period before, during, and after Orthotopic Liver Transplantation (OLT). Remote ischemic conditioning will consist of 3 cycles of 5 minutes of lower limb ischemia induced via a mid-thigh pneumatic tourniquet, followed by 5 minutes of reperfusion. Interventions will take place after anesthesia induction but before surgery, at the completion of the procedure, and on the mornings of post-operative days 1-4.

Outcome Measures

OutcomeResultp-value
PRIMARY
Percentage of Participants Completing Entire Intervention Protocol
70.96
SECONDARY
Intervention-related Pain Score
5
SECONDARY
Withdrawal of Consent Due to Pain
6; 0
SECONDARY
Percentage of Participants Who Developed Early Allograft Dysfunction (EAD)
23.3; 39.68
SECONDARY
Percentage of Participants Who Developed Prolonged Respiratory Insufficiency (PRI)
33.3; 28.57
SECONDARY
Percentage of Participants Who Developed Acute Kidney Injury (AKI) Stages 2 or 3
20.0; 25.86
SECONDARY
Time to Dialysis Discontinuation
2; 15.5
SECONDARY
Presence of Clavien-Dindo Grade IIIb or Higher Complications
51.1; 47.62
SECONDARY
Clavien-Dindo Grade IIIb or Higher - Number of Complications
1; 0
SECONDARY
Intensive Care Unit (ICU) Length of Stay (LOS)
3.5; 4
SECONDARY
Hospital LOS
13; 10
SECONDARY
Liver Allograft Survival
90; 98.41
SECONDARY
Patient Survival
90.32; 98.41
SECONDARY
Number of Subjects Not Completing Intervention Protocol
9

Eligibility Criteria

Inclusion Criteria

  • Adults (> 18 years of age) with acute and chronic liver failure requiring liver transplants or patients undergoing transplantation for hepatocellular carcinoma.
  • Both sexes
  • Written consent to participate in the study

Exclusion Criteria

  • 45
  • Pregnant patients
  • Patients in whom complete lower extremity ischemia is not achieved despite maximum tourniquet inflation to 250 mmHg during the first intervention
  • Patients with lower extremity paralysis
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02635347). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search